Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer

Tianjiao Zhou1,2,3, Zheng Li4, Yumeng Jiang1,2,3

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.

Cancer Gene Therapy
|February 5, 2024
PubMed

Insights

Circular RNAs significantly impact thyroid cancer development. This review details their roles in eight cancer hallmarks, offering insights for future research and treatments.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyroid cancer incidence is rising, with aggressive forms posing significant mortality risks.
  • Mechanisms driving thyroid cancer progression, such as recurrence and metastasis, are not fully understood.
  • Circular RNAs (circRNAs) are emerging as key regulators in various cancers.

Purpose of the Study:

  • To review and summarize identified circular RNAs in thyroid cancers over the last decade.
  • To correlate circRNAs with the established hallmarks of cancer in thyroid malignancies.
  • To identify knowledge gaps regarding circRNA involvement in thyroid cancer biology.

Main Methods:

  • Literature review of studies on circular RNAs in thyroid cancer published in the past 10 years.
  • Categorization of identified circRNAs based on the 14 hallmarks of cancer.
  • Analysis of the reported regulatory roles of circRNAs in thyroid cancer progression.

Main Results:

  • Eight of the 14 hallmarks of cancer are demonstrably regulated by circular RNAs in thyroid cancer.
  • Specific circular RNAs have been linked to key malignant features like dedifferentiation and radioiodine resistance.
  • Six hallmarks of cancer show no reported correlation with circular RNAs in thyroid cancer to date.

Conclusions:

  • Circular RNAs play a substantial role in multiple facets of thyroid cancer progression.
  • Further research into circRNA mechanisms is crucial for understanding thyroid cancer and developing novel therapies.
  • This review highlights the importance of circRNAs in endocrine oncology and potential therapeutic targets.

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.8K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K